Document Detail

Generalized oedema of newborn associated with the administration of dipyrone.
MedLine Citation:
PMID:  590280     Owner:  NLM     Status:  MEDLINE    
In fourteen infants, aged 9--60 days, with generalized oedema seen during a one year period the common denominator was the administration of dipyrone one to two days prior to the development of oedema. None of the other causes of oedema in early life could be incriminated in any of these babies. Pediatricians should be aware of this iatrogenic cause whenever they encounter a young infant with generalized oedema. Oedema disappeared in all the cases following discontinuation of dipyrone but anuria lasted for more than four days in one case. This stydy re-emphasizes the need to without this potentially dangerous drug, especially during the neonatal period.
M Bajoghli; T S Ajudani; M Gharavi
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pediatrics     Volume:  126     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  1977 Nov 
Date Detail:
Created Date:  1978-02-18     Completed Date:  1978-02-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  271-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aminopyrine / analogs & derivatives*
Anuria / chemically induced
Dipyrone / administration & dosage,  adverse effects*
Edema / chemically induced*
Infant, Newborn
Infant, Newborn, Diseases / chemically induced*
Infant, Premature
Infant, Premature, Diseases / chemically induced
Sex Factors
Reg. No./Substance:
58-15-1/Aminopyrine; 68-89-3/Dipyrone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Negative impact of growth-hormone deficiency on psychological functioning in dwarfed children and ad...
Next Document:  Intelligence level of patients with the Duchenne type of progressive muscular dystrophy (pmd-d).